FCCI First to Treat PAD Patient with TORUS Stent Graft

FCCI has another first! Dr. Ali, Vice President and Cath Lab Director at FCCI, along with the cath lab and research teams, enrolled and treated the first TORUS stent graft patient in the US. The TORUS stent graft is designed for the treatment of peripheral artery disease (PAD), a disease affecting blood flow to the lower extremities. PAD has a high mortality rate that continues to rise.

What makes the TORUS stent graft unique is its’ placement and durability. It is placed in the superficial femoral artery (SFA), which is an artery that runs the length of the thigh without any significant side branches. The graft is strong and flexible enough to correct any damage on this artery. It is a step forward in the treatment of patients with PAD.

Dr. Ali’s patient had a difficult SFA lesion that was treated with the strength and flexibility that the TORUS stent graft offered. “We are thrilled to be the first site to enroll in this important trial and to be part of bringing this technology forward as a potential option for our patients,” Dr. Ali said.